DE2128730A1 - Mittel zur Kompensierung eines Dopaminmangels im Gehirn - Google Patents

Mittel zur Kompensierung eines Dopaminmangels im Gehirn

Info

Publication number
DE2128730A1
DE2128730A1 DE19712128730 DE2128730A DE2128730A1 DE 2128730 A1 DE2128730 A1 DE 2128730A1 DE 19712128730 DE19712128730 DE 19712128730 DE 2128730 A DE2128730 A DE 2128730A DE 2128730 A1 DE2128730 A1 DE 2128730A1
Authority
DE
Germany
Prior art keywords
tyrosine
dopa
dopamine
brain
dihydroxypheny
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19712128730
Other languages
German (de)
English (en)
Inventor
Victor Joseph Harleysville Pa Lotti (V St A)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2128730A1 publication Critical patent/DE2128730A1/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19712128730 1970-06-11 1971-06-09 Mittel zur Kompensierung eines Dopaminmangels im Gehirn Granted DE2128730A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4555470A 1970-06-11 1970-06-11

Publications (1)

Publication Number Publication Date
DE2128730A1 true DE2128730A1 (de) 1971-12-16

Family

ID=21938583

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712128730 Granted DE2128730A1 (de) 1970-06-11 1971-06-09 Mittel zur Kompensierung eines Dopaminmangels im Gehirn

Country Status (10)

Country Link
US (1) US3658968A (cg-RX-API-DMAC7.html)
BE (1) BE768354A (cg-RX-API-DMAC7.html)
CA (1) CA968273A (cg-RX-API-DMAC7.html)
DE (1) DE2128730A1 (cg-RX-API-DMAC7.html)
FR (1) FR2100748B1 (cg-RX-API-DMAC7.html)
GB (1) GB1294812A (cg-RX-API-DMAC7.html)
IE (1) IE35335B1 (cg-RX-API-DMAC7.html)
IL (1) IL36967A (cg-RX-API-DMAC7.html)
NL (1) NL148240B (cg-RX-API-DMAC7.html)
ZA (1) ZA713756B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5852219A (ja) * 1981-09-22 1983-03-28 Sumitomo Chem Co Ltd パ−キンソン病治療剤

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891768A (en) * 1970-03-10 1975-06-24 Haessle Ab Treatment of Parkinson{3 s disease
WO1991002523A1 (en) * 1989-08-17 1991-03-07 The Children's Medical Center Corporation Glutamatergic amino acid agonists and antagonists
JPH07505908A (ja) * 1992-09-28 1995-06-29 マックセチーニ、マリア　ルイザ Ｎｍｄａ受容体のアロステリックモジュレーター
US20140323575A1 (en) * 2011-11-11 2014-10-30 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) Tyrosine isomers as therapeutic agents
CN111655243A (zh) * 2018-01-29 2020-09-11 乔纳森·萨克纳-伯恩斯坦 在人类神经系统疾病中调节多巴胺的方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5852219A (ja) * 1981-09-22 1983-03-28 Sumitomo Chem Co Ltd パ−キンソン病治療剤

Also Published As

Publication number Publication date
BE768354A (fr) 1971-12-10
IE35335L (en) 1971-12-11
NL148240B (nl) 1976-01-15
IL36967A (en) 1974-06-30
NL7107177A (cg-RX-API-DMAC7.html) 1971-12-14
FR2100748B1 (cg-RX-API-DMAC7.html) 1974-08-30
CA968273A (en) 1975-05-27
US3658968A (en) 1972-04-25
IL36967A0 (en) 1971-08-25
FR2100748A1 (cg-RX-API-DMAC7.html) 1972-03-24
IE35335B1 (en) 1976-01-21
ZA713756B (en) 1973-01-31
GB1294812A (cg-RX-API-DMAC7.html) 1972-11-01

Similar Documents

Publication Publication Date Title
DE3688296T2 (de) Arzneimittel zur behandlung von erbrechen.
DE69710390T2 (de) Pharmazeutische Zusammensetzungen mit Mirtazapin und einem oder mehreren selektiven Serotonin-Aufnahme Inhibitoren
DE69034223T2 (de) Sertralin zur Behandlung der sozialen Phobie
DE3586545T2 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE69012261T2 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DE3530046A1 (de) Aethylendiaminmonoamid-derivate
DE3213788A1 (de) Analgetikum und dessen anwendung
DE69110779T2 (de) Schilddrüsenhormone zur kardialen behandlung.
DE2513940A1 (de) Pharmazeutische zubereitung
DE2128730A1 (de) Mittel zur Kompensierung eines Dopaminmangels im Gehirn
DE2362123A1 (de) Pharmazeutische zubereitungen
DE60123528T2 (de) Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit
DE69001526T2 (de) Verwendung von Trifluormethylphenyltetrahydropyridinen zur Herstellung von Arzneimitteln zur Bekämpfung intestinaler Motilitätsstörungen.
DE69004529T2 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
DE2348577C2 (de) 1-Amino-4-phenyl-1,2,3,4-tetrahydronaphthaline, deren pharmakologisch verträglichen Salze und diese enthaltende pharmazeutische Zubereitungen
DE69529109T2 (de) Venlafaxin und seine Analoga zum Herbeiführen einer Verbesserung der kognitiven Funktionen
DE2513597B2 (de) L-5-hydroxytryptophan-l-glutamatmonohydrat, verfahren zu seiner herstellung und arzneimittel
DE2855306A1 (de) Mittel zur senkung der herzfrequenz
DE2527628B2 (de) N-vinyloxyaethyl-alpha-methyl-beta- phenaethylamine und appetitzuegler auf deren basis
DE2636328A1 (de) Arzneimittel
DE1695832C3 (de) B1,3-biphenylpyrazolin-Derivate und Verfahren zu ihrer Herstellung
DE69001038T2 (de) Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.
DE2512893A1 (de) Zusammensetzung zum zeitweiligen abschwaechen von depressionssymptomen
DE1949376A1 (de) Behandlungsverfahren
DE1670061C (de) 2 (2' Pyndyloxy)-athylguamdin und Verfahren zu dessen Herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
8328 Change in the person/name/address of the agent

Free format text: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee